MSI-H Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
Gastric CancerColon CancerMSI-H+1 more
Peking University38 enrolled1 locationNCT06580574
Recruiting
Phase 1Phase 2
Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
Rectal CancerRadiotherapyAnti-PD-1 Antibody+2 more
West China Hospital20 enrolled1 locationNCT04636008